India: Pharma Firms Don't Need NOC for Exporting Drugs, Medical Devices
To ensure ease of doing business, the Central Drugs Standard Control Organization (CDSCO) has waived the provision of procuring ‘no-objection certificate’ (NOC) by pharmaceutical companies for exporting drugs, medical devices and cosmetics across ports in the country.
Previously, licensed manufacturers of drugs and medical devices could export them only to the US, Canada, Japan, Australia and the European Union with the NOC. Now CDSCO has extended the rule for exports to all other countries.
In a notice issued recently, the CDSCO said the NOC for licensed manufacturers will be waived if “shipping bills” submitted by the manufacturer include a copy of its “valid licence”. “This is being done to bring ease in drug regulatory practices in India relating to export of drugs, medical devices and cosmetics. All the stakeholders are, however, required to comply with the regulatory requirements of the importing countries as per their specific needs,” the notice stated.
Looking for chemical products? Let suppliers reach out to you!
2026-07-06
-
Life Sciences Industry Overview
The coverage spans the global life sciences industry across pharmaceuticals and food & nutrition, tracking the shift from lowest-cost sourcing to supply continuity, quality, and risk management, along with product trends and the growing edge of differentiated, globally capable players.Published in: June.2026
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
India Imposes Final Anti‑Dumping Duties on Ethylenediamine from China, EU, Saudi Arabia, and Taiwan, China, with Top Rate of $575/tonne
-
Urea Prices Surge as India Faces Critical Shortages: Will China’s Export Quotas Provide Relief?
-
India Extends Anti-Dumping Duties on Aniline Imports from China for Five More Years
-
Covestro India and CSIR-NCL Collaborate to Transform Polyurethane Waste
-
India Imposes Anti-Dumping Duties on Chinese vitamin A Palmitate and Insoluble Sulfur Products
-
Indian Government Increases Excise Duty on Petrol and Diesel
-
India Considers Removing Taxes on U.S. Liquefied Natural Gas to Boost Imports
-
India Imposes Anti-Dumping Duties on Five Chinese Products Including Aluminum Foil, Trichloroisocyanuric Acid
-
Gulbrandsen to Increase PE Wax Capacity and Build New Polymer Plant in India
-
India imposes anti-dumping duties on water treatment chemicals from China, Japan
Recommend Reading
-
Pfizer Seen Holding Strategic Edge in Bidding Battle for Metsera
-
Cipla CEO Calls Tirzepatide a High-Science Product with Strong Market Outlook
-
Novo Nordisk Enters High-Stakes Bidding War with Pfizer for Metsera
-
Canada Issues Non-Compliance Notice to Dr. Reddy’s on Semaglutide Generic
-
Strides Pharma Reports Strong Q2 as Net Profit Surges 82%
-
In November, the coke market in China was mainly strong.
-
Narrow Fluctuations in the MTBE Market in November in China
-
At the end of the month, the 180CST fuel oil market in China remains stable
-
Since November, the phenol market in China has seen more declines than increases
-
China's Soda Ash Market Remains Stable